2024 Q2 Form 10-Q Financial Statement

#000136495424000042 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $163.1M $174.4M $187.6M
YoY Change -10.78% -7.06% -7.24%
Cost Of Revenue $45.41M $46.50M $49.15M
YoY Change -4.22% -5.4% -10.77%
Gross Profit $117.7M $127.9M $138.5M
YoY Change -13.07% -7.65% -5.92%
Gross Profit Margin 72.17% 73.33% 73.8%
Selling, General & Admin $77.56M $85.91M $95.99M
YoY Change -23.41% -10.5% 7.41%
% of Gross Profit 65.88% 67.19% 69.33%
Research & Development $43.65M $44.44M $46.91M
YoY Change -17.44% -5.27% -10.51%
% of Gross Profit 37.08% 34.75% 33.88%
Depreciation & Amortization $19.71M $19.69M $25.54M
YoY Change -25.59% -22.93% 17.14%
% of Gross Profit 16.74% 15.4% 18.45%
Operating Expenses $602.7M $130.3M $142.9M
YoY Change 291.04% -8.78% 0.79%
Operating Profit -$485.0M -$2.491M -$4.446M
YoY Change 2494.18% -43.97% -182.7%
Interest Expense -$651.0K -$650.0K $11.26M
YoY Change -106.82% -105.77% 662.56%
% of Operating Profit
Other Income/Expense, Net $6.468M $10.78M $10.81M
YoY Change -2048.19% -0.26% 135.83%
Pretax Income -$478.5M $7.639M $6.362M
YoY Change -1180.39% 20.07% -36.12%
Income Tax $138.3M $9.059M $4.176M
% Of Pretax Income 118.59% 65.64%
Net Earnings -$616.9M -$1.420M $2.186M
YoY Change -2606.44% -164.96% -61.93%
Net Earnings / Revenue -378.12% -0.81% 1.17%
Basic Earnings Per Share -$6.01 -$0.01 $0.02
Diluted Earnings Per Share -$6.01 -$0.01 $0.02
COMMON SHARES
Basic Shares Outstanding 102.2M shares 102.9M shares 126.6M shares
Diluted Shares Outstanding 102.6M shares 102.3M shares 124.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $345.5M $390.8M $559.2M
YoY Change -10.28% -30.12% -52.74%
Cash & Equivalents $133.1M $96.75M $281.3M
Short-Term Investments $212.4M $247.0M $277.9M
Other Short-Term Assets $36.28M $50.44M $30.83M
YoY Change -11.5% 63.59% 110.16%
Inventory
Prepaid Expenses $30.84M $20.43M $25.49M
Receivables $20.96M $24.74M $22.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $433.5M $465.9M $637.5M
YoY Change -2.95% -26.91% -48.86%
LONG-TERM ASSETS
Property, Plant & Equipment $179.3M $212.0M $201.3M
YoY Change -20.88% 5.29% 7.22%
Goodwill $189.8M $628.8M $622.7M
YoY Change -69.86% 0.98% -2.9%
Intangibles $12.85M $48.14M $73.09M
YoY Change -81.0% -34.13% -28.83%
Long-Term Investments $259.9M $221.7M $613.9M
YoY Change -38.52% -63.89% 40.98%
Other Assets $15.17M $156.2M $19.82M
YoY Change -91.35% 687.74% 3.35%
Total Long-Term Assets $680.8M $1.267B $1.724B
YoY Change -55.27% -26.54% 21.79%
TOTAL ASSETS
Total Short-Term Assets $433.5M $465.9M $637.5M
Total Long-Term Assets $680.8M $1.267B $1.724B
Total Assets $1.114B $1.733B $2.362B
YoY Change -43.39% -26.64% -11.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.42M $20.12M $13.06M
YoY Change 11.35% 54.07% 36.75%
Accrued Expenses $68.00M $73.56M $68.03M
YoY Change -11.29% 8.13% -20.37%
Deferred Revenue $45.02M $54.06M $58.57M
YoY Change -15.37% -7.7% -3.13%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $357.8M $357.5M
YoY Change
Total Short-Term Liabilities $485.3M $505.2M $139.7M
YoY Change 239.81% 261.75% -10.15%
LONG-TERM LIABILITIES
Long-Term Debt $243.1M $242.9M $1.190B
YoY Change -68.31% -79.58% -29.17%
Other Long-Term Liabilities $4.870M $21.06M $2.662M
YoY Change -79.43% 691.25% -59.22%
Total Long-Term Liabilities $263.5M $264.0M $1.215B
YoY Change -66.67% -78.28% -28.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $485.3M $505.2M $139.7M
Total Long-Term Liabilities $263.5M $264.0M $1.215B
Total Liabilities $748.8M $769.2M $1.355B
YoY Change -19.79% -43.24% -26.91%
SHAREHOLDERS EQUITY
Retained Earnings -$670.7M -$53.79M -$68.37M
YoY Change 1432.8% -21.32% -79.37%
Common Stock $1.076B $1.058B $1.120B
YoY Change -4.09% -5.58% -4.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $365.5M $963.5M $1.007B
YoY Change
Total Liabilities & Shareholders Equity $1.114B $1.733B $2.362B
YoY Change -43.39% -26.64% -11.29%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$616.9M -$1.420M $2.186M
YoY Change -2606.44% -164.96% -61.93%
Depreciation, Depletion And Amortization $19.71M $19.69M $25.54M
YoY Change -25.59% -22.93% 17.14%
Cash From Operating Activities $14.23M $53.32M $73.16M
YoY Change -77.33% -27.12% -8.59%
INVESTING ACTIVITIES
Capital Expenditures $17.80M $28.02M $17.17M
YoY Change 6.6% 63.21% -41.88%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$5.482M -$12.80M -$89.61M
YoY Change -102.17% -85.72% -72.83%
Cash From Investing Activities -$23.28M -$40.81M -$106.8M
YoY Change -109.86% -61.78% -70.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.341M -4.294M -$158.9M
YoY Change -99.67% -97.3% -48.32%
NET CHANGE
Cash From Operating Activities 14.23M 53.32M $73.16M
Cash From Investing Activities -23.28M -40.81M -$106.8M
Cash From Financing Activities -1.341M -4.294M -$158.9M
Net Change In Cash -10.40M 8.210M -$192.3M
YoY Change -90.19% -104.27% -67.17%
FREE CASH FLOW
Cash From Operating Activities $14.23M $53.32M $73.16M
Capital Expenditures $17.80M $28.02M $17.17M
Free Cash Flow -$3.573M $25.30M $55.99M
YoY Change -107.76% -54.81% 10.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101569933 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101569933 shares
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
49150000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
46497000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Gross Profit
GrossProfit
127853000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
138451000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44435000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46907000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30375000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37017000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55534000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58973000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
130344000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
142897000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2491000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4446000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-650000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1268000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10780000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12076000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10130000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10808000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7639000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6362000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9059000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4176000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102343000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102343000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124304000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1970000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3812000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3963000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8338000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5933000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12150000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7353000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14336000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
944618000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
114000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-4293000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30616000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5933000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
963474000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1116589000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
151311000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
144000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7735000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34736000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12150000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1006759000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29289000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
33746000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19687000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25543000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2877000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3441000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1567000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1496000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
541000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1057000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-478000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-120000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
5000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6705000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1578000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-3583000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-8485000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1270000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2803000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6589000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-336000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1159000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2012000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
640000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2569000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1580000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6397000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53318000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73160000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28017000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17166000 usd
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
79028000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
497372000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
50731000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
407759000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
15500000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40814000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-106779000 usd
CY2024Q1 chgg Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
0 usd
CY2023Q1 chgg Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
145000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4294000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7736000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
151311000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4294000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158902000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-226000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7984000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-192334000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137976000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475854000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145960000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283520000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
224000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
437000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
641000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2017000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2216000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2866000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12407000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
6302000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
3941000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143747000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281302000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
224000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
63000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1989000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2155000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145960000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283520000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1300000 usd
CY2024Q1 chgg Increase Decrease In Contract With Customer Liability Percent
IncreaseDecreaseInContractWithCustomerLiabilityPercent
-0.02
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities; the disclosure of contingent liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting periods. We base our estimates on historical experience, knowledge of current business conditions, and various other factors we believe to be reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our financial position and results of operations.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174350000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187601000 usd
CY2024Q1 chgg Revenue From Contract With Customer Including Assessed Tax Increase Decrease
RevenueFromContractWithCustomerIncludingAssessedTaxIncreaseDecrease
-13251000 usd
CY2024Q1 chgg Revenue From Contract With Customer Including Assessed Tax Increase Decrease Percent
RevenueFromContractWithCustomerIncludingAssessedTaxIncreaseDecreasePercent
-0.07
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
37500000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
39100000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24741000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31404000 usd
CY2024Q1 chgg Increase Decrease In Accounts Receivable Net
IncreaseDecreaseInAccountsReceivableNet
-6663000 usd
CY2024Q1 chgg Increase Decrease In Accounts Receivable Percent
IncreaseDecreaseInAccountsReceivablePercent
-0.21
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7973000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8598000 usd
CY2024Q1 chgg Increase Decrease In Contract With Customer Assets
IncreaseDecreaseInContractWithCustomerAssets
-625000 usd
CY2024Q1 chgg Increase Decrease In Contract With Customer Assets Percent
IncreaseDecreaseInContractWithCustomerAssetsPercent
-0.07
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
54056000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
55336000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1280000 usd
CY2024Q1 chgg Increase Decrease In Contract With Customer Liability Percent
IncreaseDecreaseInContractWithCustomerLiabilityPercent
-0.02
CY2024Q1 chgg Increase Decrease In Accounts Receivable Net
IncreaseDecreaseInAccountsReceivableNet
-6700000 usd
CY2024Q1 chgg Increase Decrease In Accounts Receivable Percent
IncreaseDecreaseInAccountsReceivablePercent
-0.21
CY2024Q1 chgg Increase Decrease In Contract With Customer Assets
IncreaseDecreaseInContractWithCustomerAssets
-600000 usd
CY2024Q1 chgg Increase Decrease In Contract With Customer Assets Percent
IncreaseDecreaseInContractWithCustomerAssetsPercent
-0.07
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102343000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102343000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102343000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124304000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16226000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24509000 shares
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
247976000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
247013000 usd
CY2024Q1 chgg Available For Sale Securities Debt Maturities Year One Through Three Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesYearOneThroughThreeAmortizedCostBasis
222409000 usd
CY2024Q1 chgg Available For Sale Securities Debt Maturities Year One Through Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearOneThroughThreeFairValue
221665000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
96751000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
96751000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
567136000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
565429000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
7000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29289000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33746000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1300000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001364954-24-000042-index-headers.html Edgar Link pending
0001364954-24-000042-index.html Edgar Link pending
0001364954-24-000042.txt Edgar Link pending
0001364954-24-000042-xbrl.zip Edgar Link pending
chgg-20240331.htm Edgar Link pending
chgg-20240331.xsd Edgar Link pending
chgg-20240331_g1.jpg Edgar Link pending
ex10012024-03x31.htm Edgar Link pending
ex10022024-03x31.htm Edgar Link pending
ex31012024-03x31.htm Edgar Link pending
ex31022024-03x31.htm Edgar Link pending
ex32012024-03x31.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
chgg-20240331_cal.xml Edgar Link unprocessable
chgg-20240331_def.xml Edgar Link unprocessable
chgg-20240331_lab.xml Edgar Link unprocessable
chgg-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chgg-20240331_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending